Skip to main
IQV

IQVIA Hlds (IQV) Stock Forecast & Price Target

IQVIA Hlds (IQV) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 47%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

IQVIA Holdings is experiencing robust growth in its FSP, RWE, and CSMS segments, with notable year-over-year increases in Q3. The company is capitalizing on improved client decision timelines and a strong pipeline, bolstered by recent drug launches, which have contributed to a positive commercial momentum. Furthermore, IQVIA's improved pricing environment, alongside a significant enhancement in their win rate, positions the company well for sustained performance, with a projected growth rate of over 4% in its R&DServices segment on a constant currency, excluding COVID-related impacts.

Bears say

The financial analysis indicates a deteriorating outlook for IQVIA Holdings, driven primarily by a decline in year-over-year constant currency growth rates, which have dropped significantly from 6.8% in 2Q25 to 3.8% in the most recent quarter. Furthermore, the company's acknowledgment of potential challenges in maintaining 2026 revenue growth above 5% raises concerns about its ability to sustain momentum, particularly in the Real World Evidence (RWE) segment, which is expected to face tough comparisons. Additionally, rising interest rates pose a further risk to earnings, as the company navigates the impact of its floating versus fixed-rate debt obligations amidst a slowdown in hiring and operational productivity.

IQVIA Hlds (IQV) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 47% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IQVIA Hlds (IQV) Forecast

Analysts have given IQVIA Hlds (IQV) a Buy based on their latest research and market trends.

According to 15 analysts, IQVIA Hlds (IQV) has a Buy consensus rating as of Jan 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $246.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $246.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IQVIA Hlds (IQV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.